The Effect of Cardiac Rehabilitation in Paediatric Fontan Circulation Patients: A Prospective Intervention Study

Luna van de Ven1, Ana Clara Félix2,3, Joana Suarez2,3

  • 1Department of Paediatric Cardiology, Children's Hospital, University Medical Center Utrecht, P.O. Box 85090, 3508 Utrecht, The Netherlands.

PubMed

Insights

Cardiac rehabilitation (CR) significantly enhances exercise capacity and quality of life for Fontan procedure patients. This structured program shows promise for improving outcomes in individuals with univentricular heart physiology.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Rehabilitation
  • Congenital Heart Disease

Background:

  • The Fontan procedure, a palliative surgery for univentricular heart physiology, is associated with reduced exercise capacity and quality of life.
  • Evidence-based strategies are needed to improve long-term outcomes for Fontan survivors.
  • Cardiac rehabilitation (CR) is a potential intervention to mitigate these deficits.

Purpose of the Study:

  • To evaluate the impact of a structured cardiac rehabilitation program on exercise capacity and health-related quality of life (HRQOL) in Fontan patients.
  • To assess the safety and feasibility of CR in this specific patient population.
  • To inform the integration of CR into standard care for Fontan survivors.

Main Methods:

  • A cohort of ten Fontan patients (aged 8-30 years) underwent a structured CR program for at least three months.
  • The program included supervised aerobic and resistance training, alongside educational and nutritional guidance.
  • Assessments included cardiorespiratory fitness (VO2 max, %pred VO2), haemodynamics, daily activity, HRQOL (SF-36), and NT-proBNP levels.

Main Results:

  • Significant improvements were observed in cardiorespiratory fitness, including VO2 max (p=0.0089) and percent predicted VO2 (p=0.005).
  • All domains of the SF-36 questionnaire demonstrated significant gains in HRQOL (p < 0.001).
  • The CR program was safe, with high adherence (85-93%) and no adverse events reported; NT-proBNP levels also decreased.

Conclusions:

  • Cardiac rehabilitation significantly improves exercise capacity and HRQOL in Fontan patients, including those with a right systemic ventricle.
  • These findings support the integration of physical conditioning into the standard care of Fontan survivors.
  • Further research is warranted to optimize CR protocols and confirm long-term benefits for reducing morbidity and mortality.

Related Concept Videos

Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
12
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
1
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
1